138 related articles for article (PubMed ID: 11581007)
21. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
Huang QL; Feig DS; Blackstein ME
J Endocrinol Invest; 2000 Apr; 23(4):263-7. PubMed ID: 10853715
[TBL] [Abstract][Full Text] [Related]
22. Tumour-induced osteomalacia.
Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
[TBL] [Abstract][Full Text] [Related]
23. A Patient of Tumour Induced Osteomalacia Undiagnosed for 11 years.
Gokhale N; Gokhale Y; Mahajan P
J Assoc Physicians India; 2018 Apr; 66(4):81-4. PubMed ID: 30347965
[TBL] [Abstract][Full Text] [Related]
24. Sporadic adult-onset hypophosphatemic osteomalacia caused by excessive action of fibroblast growth factor 23.
Hoshino C; Satoh N; Sugawara S; Kuriyama C; Kikuchi A; Ohta M
Intern Med; 2008; 47(5):453-7. PubMed ID: 18310982
[TBL] [Abstract][Full Text] [Related]
25. Tumor-induced osteomalacia: lessons learned.
Lewiecki EM; Urig EJ; Williams RC
Arthritis Rheum; 2008 Mar; 58(3):773-7. PubMed ID: 18311810
[TBL] [Abstract][Full Text] [Related]
26. Oncogenic osteomalacia presenting as bilateral stress fractures of the tibia.
Ohashi K; Ohnishi T; Ishikawa T; Tani H; Uesugi K; Takagi M
Skeletal Radiol; 1999 Jan; 28(1):46-8. PubMed ID: 10068075
[TBL] [Abstract][Full Text] [Related]
27. Renal hypophosphatemic osteomalacia unmasked by hyperthyroidism.
Baranetsky NG; Chertow BS; Sivitz WI; Mullen JO
Am J Med Sci; 1986 Oct; 292(4):231-4. PubMed ID: 3019139
[TBL] [Abstract][Full Text] [Related]
28. A case of severe osteomalacia caused by Tubulointerstitial nephritis with Fanconi syndrome in asymptomotic primary biliary cirrhosis.
Yamaguchi S; Maruyama T; Wakino S; Tokuyama H; Hashiguchi A; Tada S; Homma K; Monkawa T; Thomas J; Miyashita K; Kurihara I; Yoshida T; Konishi K; Hayashi K; Hayashi M; Itoh H
BMC Nephrol; 2015 Nov; 16():187. PubMed ID: 26554665
[TBL] [Abstract][Full Text] [Related]
29. [Hypophosphatemic osteomalacia secondary to a vascular fibrous histiocytoma].
Insua Vilariño SA; Díaz Garel J; Caamaño Freire M; Mera Varela A; Buelta Carrillo L; Pérez Becerra E; Varela Durán J
Rev Clin Esp; 1993 Oct; 193(6):293-5. PubMed ID: 8259452
[TBL] [Abstract][Full Text] [Related]
30. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient].
Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B
Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case.
Dupond JL; Mahammedi H; Prié D; Collin F; Gil H; Blagosklonov O; Ricbourg B; Meaux-Ruault N; Kantelip B
Bone; 2005 Mar; 36(3):375-8. PubMed ID: 15777669
[TBL] [Abstract][Full Text] [Related]
32. Metastatic prostate cancer presenting as tumour-induced osteomalacia.
Layman AAK; Joshi S; Shah S
BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31315844
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic osteomalacia: lesion detection by MR skeletal survey.
Avila NA; Skarulis M; Rubino DM; Doppman JL
AJR Am J Roentgenol; 1996 Aug; 167(2):343-5. PubMed ID: 8686600
[No Abstract] [Full Text] [Related]
34. Oncogenic osteomalacia associated with a mesenchymal chondrosarcoma.
Stone E; Bernier V; Rabinovich S; From GL
Clin Invest Med; 1984; 7(3):179-85. PubMed ID: 6518684
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic osteomalacia: strange tumours in strange places.
Weiss D; Bar RS; Weidner N; Wener M; Lee F
Postgrad Med J; 1985 Apr; 61(714):349-55. PubMed ID: 4022870
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor.
Koriyama N; Nishimoto K; Kodama T; Nakazaki M; Kurono Y; Yoshida H; Tei C
Am J Med Sci; 2006 Sep; 332(3):142-7. PubMed ID: 16969146
[TBL] [Abstract][Full Text] [Related]
37. Case report: Solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET/CT. A case report with a review of the radiological literature.
Chua SC; O'Connor SR; Wong WL; Ganatra RH
Br J Radiol; 2008 Apr; 81(964):e110-4. PubMed ID: 18344267
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic osteomalacia, a rare paraneoplastic syndrome due to phosphate wasting--a case report and review of the literature.
Woznowski M; Quack I; Stegbauer J; Büchner N; Rump LC; Schieren G
Clin Nephrol; 2008 Nov; 70(5):431-8. PubMed ID: 19000546
[TBL] [Abstract][Full Text] [Related]
39. [Chronic bone pain due to raised FGF23 production? The importance of determining phosphate levels].
de Jongh RT; Vervloet MG; Bravenboer N; Heijboer AC; den Heijer M; Lips P
Ned Tijdschr Geneeskd; 2013; 157(28):A5908. PubMed ID: 23841927
[TBL] [Abstract][Full Text] [Related]
40. Oncogenic osteomalacia caused by a phosphaturic mesenchymal tumor of the oral cavity: a case report.
Yang IM; Park YK; Hyun YJ; Kim DY; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
Korean J Intern Med; 1997 Jan; 12(1):89-95. PubMed ID: 9159046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
